Loading...
Do Patient Characteristics Moderate the Effect of Extended-Release Naltrexone (XR-NTX) for Opioid Use Disorder?
BACKGROUND: Extended release naltrexone (XR-NTX) injected intramuscularly monthly has been shown to reduce relapse in persons with opioid use disorder. Baseline factors, including patients’ demographics, comorbidities and lifestyle, may help identify patients who will benefit most or least from XR-N...
Na minha lista:
| Udgivet i: | J Subst Abuse Treat |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5565721/ https://ncbi.nlm.nih.gov/pubmed/28236511 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsat.2017.01.018 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|